THURSDAY, Oct. 5, 2023 — Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19.
In interim findings from a Phase 1/2 trial, the vaccine showed both a…
THURSDAY, Oct. 5, 2023 — Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19.
In interim findings from a Phase 1/2 trial, the vaccine showed both a…